We hypothesized that this combination would offer high diagnostic yield both in relation to the DMD gene but also other genes of potential etiological significance and thereby offer a cost-effective approach to genetic diagnosis in DMD patients in developing countries. This evidence concerns the gene DMD and Duchenne muscular dystrophy.